Erschienen in:
31.08.2020 | COVID-19 | Brief Report
Zur Zeit gratis
Prevalence and outcomes of re-positive nucleic acid tests in discharged COVID-19 patients
verfasst von:
Hou-wei Du, Jun-nian Chen, Xiao-bin Pan, Xiao-ling Chen, Yixian-Zhang, Shuang-fang Fang, Xiao-qing Li, Pin-cang Xia, Lei Gao, Hai-long Lin, Li-min Chen, Nan Liu, On behalf of Fujian Medical Team Support Wuhan for COVID-19
Erschienen in:
European Journal of Clinical Microbiology & Infectious Diseases
|
Ausgabe 2/2021
Einloggen, um Zugang zu erhalten
Abstract
The prevalence and outcomes of patients who had re-activation of coronavirus disease 2019 (COVID-19) after discharge remain poorly understood. We included 126 consecutively confirmed cases of COVID-19 with 2-month follow-up data after discharge in this retrospective study. The upper respiratory specimen using a reverse-transcription polymerase chain reaction test of three patients (71 years [60–76]) were positive within 11–20 days after their discharge, with an event rate of 19.8 (95%CI 2.60–42.1) per 1,000,000 patient-days. Moreover, all re-positive patients were asymptomatic. Our findings suggest that few recovered patients may still be virus carriers even after reaching the discharge criteria.